Exact Sciences: Improved Accuracy of Second-gen Cologuard® Test

 Data Presented Include Prospective and Case-collected Samples and Show Improved Specificity of 92%, High Sensitivity for Colorectal Cancer at 95%, and Precancerous Lesion Sensitivity of 57%

Data Presented at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI)

Exact Sciences and Mayo Clinic will Host a Conference Call and Webcast at 11 a.m. ET on Wednesday, January 19 to Discuss Results of the Study

Conference call and webcast details

Exact Sciences management and Mayo Clinic will host a conference call and webcast on Wednesday, Jan. 19, 2022, at 11 a.m. ET to discuss results of the second-generation Cologuard study. The webcast will be available at www.exactsciences.com. Domestic callers should dial (833) 952-1519 and international callers should dial +1 236-714-2125. The access code for both domestic and international callers is 3972189.

An archive of the webcast will be available at www.exactsciences.com. A replay of the conference call will be available by calling 800-585-8367 domestically or +1-416-621-4642 internationally. The access code for the replay of the call is 3972189. The webcast, conference call, and replay are open to all interested parties.

https://finance.yahoo.com/news/exact-sciences-presents-data-showing-220100484.html